An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease

This study has been completed.
Sponsor:
Information provided by:
Link Medicine Corporation
ClinicalTrials.gov Identifier:
NCT01013610
First received: November 12, 2009
Last updated: March 14, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)